Partial
Mostly Aligned
Patient Risk:
Info
Summary
Several claims align with provided label text (mechanism, LDL reduction, grapefruit juice affecting atorvastatin concentrations, CYP3A4-related effects, myopathy description). However, multiple claims are unsupported or overgeneralize beyond label support (e.g., furanocoumarins/bergamottin specifics, patent/generics, oranges/lemons all-citrus assertions). Several safety claims (bleeding; generalized 'liver damage/kidney problems' from elevated levels) are not explicitly supported in the provided sections.
Category Scores
Accurate Statements
Lipitor (atorvastatin) inhibits HMG-CoA reductase/cholesterol synthesis in the liver.
12.1 Mechanism of Action
Lowering LDL-C with Lipitor can reduce risk of myocardial infarction and stroke (cardiovascular risk reduction).
1.1 Prevention of Cardiovascular Disease; 12.1 Mechanism of Action
Grapefruit juice can increase plasma concentrations of atorvastatin, especially with excessive grapefruit juice consumption.
7.2 Grapefruit Juice; 12.3 Pharmacokinetics (Table 3)
Increased plasma concentrations of atorvastatin/myopathy risk are discussed for drug interactions with statins (myopathy defined as muscle aches/weakness with high CPK).
5.1 Skeletal Muscle; 12.3 Pharmacokinetics; 7 DRUG INTERACTIONS
Unsupported Statements
Citrus fruits (including oranges, grapefruit, and lemons) contain furanocoumarins.
Provided label excerpts do not mention furanocoumarins or oranges/lemons.
Furanocoumarins in citrus fruits (particularly bergamottin and dihydroxybergamottin) can inhibit CYP3A4.
Provided label excerpts do not mention these compounds or furanocoumarins.
Elevated atorvastatin levels can increase the risk of bleeding.
No bleeding risk statement appears in the supplied label sections.
A study published in the Journal of Clinical Pharmacology reported grapefruit juice causes significantly higher atorvastatin blood levels.
Label provided supports grapefruit juice increasing plasma concentrations, but does not reference the journal or substantiate the specific 'significantly' phrasing/source.
Patients can reduce the risk of the interaction by choosing alternative fruits/juices that do not contain furanocoumarins.
No guidance about alternative fruits/juices or furanocoumarin-containing foods appears in the supplied excerpts.
Patients should consult a healthcare professional or registered dietitian for personalized advice.
Counseling exists, but 'registered dietitian' specificity is not supported in the provided excerpts.
The patent for atorvastatin (Lipitor) expired in 2011, allowing generic versions to become available.
No patent/generic availability information appears in the supplied label excerpts.
Contradictions
Low
AI Statement
All citrus fruits (including grapefruit, orange, and lemon) contain furanocoumarins and can interact negatively with Lipitor.
Label Reference
7.2 Grapefruit Juice (grapefruit juice specifically); provided excerpts do not support oranges/lemons or furanocoumarins.
Important Omissions
No boxed warning/contraindication evaluation: the provided dataset does not include those label sections, so any label-alignment for those topics cannot be verified against the AI claims.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Info
Some claims are unsupported and could lead to overly broad dietary restrictions (e.g., oranges/lemons) or incorrect counseling. However, the key on-label interaction (grapefruit juice increasing atorvastatin concentrations) and the on-label description of muscle-related risks with statin interactions are broadly aligned with provided label excerpts. Bleeding and kidney/liver linkage are not explicitly supported in the provided excerpts, which may misinform risk characterization.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Multiple overgeneralizations beyond label support (all citrus fruits; furanocoumarins/bergamottin/dihydroxybergamottin; oranges/lemons avoidance) and several unsupported safety/counseling/patent claims.
Suggested Improvement
Restrict interaction claims to grapefruit juice as described in the provided label (CYP3A4 inhibition and increased atorvastatin concentrations, especially with excessive consumption). Remove unsupported claims about furanocoumarins/bergamottin specifics, oranges/lemons, bleeding risk, patent expiration, and 'registered dietitian' specificity unless supported by the provided label text.